$SSY
SUNLINK HEALTH SYSTEMS INC

2019 Form 10-K Financial Statement

#000156459019035757 Filed on September 27, 2019

View on sec.gov

Income Statement

Concept 2019 2018 Q2 2018
Revenue $45.62M $12.21M $45.21M
YoY Change 0.9% -0.6% -15.16%
Cost Of Revenue $18.94M $3.906M $18.53M
YoY Change 2.22% -9.79% -6.97%
Gross Profit $26.68M $8.308M $26.68M
YoY Change -0.01% 4.37% -20.05%
Gross Profit Margin 58.48% 68.02% 59.01%
Selling, General & Admin $23.55M $7.380M $22.63M
YoY Change 4.08% 1.37% -21.95%
% of Gross Profit 88.27% 88.83% 84.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.728M $526.0K $1.858M
YoY Change -7.0% -2.59% -6.49%
% of Gross Profit 6.48% 6.33% 6.96%
Operating Expenses $28.86M $9.392M $46.32M
YoY Change -37.69% 0.56% -19.25%
Operating Profit -$2.314M -$1.084M -$1.112M
YoY Change 108.09% -21.45% -75.34%
Interest Expense $241.0K -$57.00K $359.0K
YoY Change -32.87% -56.15% -43.46%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.078M -$1.153M -$571.0K
YoY Change 263.92% -62.07% -76.89%
Income Tax -$82.00K -$49.00K -$345.0K
% Of Pretax Income
Net Earnings -$1.754M -$1.454M -$1.593M
YoY Change 10.11% -39.62% -159.26%
Net Earnings / Revenue -3.84% -11.9% -3.52%
Basic Earnings Per Share -$0.25 -$0.19
Diluted Earnings Per Share -$0.25 -$195.4K -$0.19
COMMON SHARES
Basic Shares Outstanding 7.149M 7.417M shares 8.283M
Diluted Shares Outstanding 7.149M 8.283M

Balance Sheet

Concept 2019 2018 Q2 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.742M $3.456M $3.456M
YoY Change 124.02% -67.09% -67.07%
Cash & Equivalents $7.742M $3.456M $3.456M
Short-Term Investments
Other Short-Term Assets $2.185M $2.937M $2.937M
YoY Change -25.6% -28.37% -27.7%
Inventory $2.016M $1.854M $1.894M
Prepaid Expenses
Receivables $4.715M $4.823M $4.823M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.66M $13.11M $13.11M
YoY Change 27.06% -42.05% -42.05%
LONG-TERM ASSETS
Property, Plant & Equipment $5.243M $5.896M $10.41M
YoY Change -49.62% -42.7% 1.13%
Goodwill
YoY Change
Intangibles $1.470M
YoY Change -7.37%
Long-Term Investments
YoY Change
Other Assets $1.012M $885.0K $885.0K
YoY Change 14.35% 5.61% 5.61%
Total Long-Term Assets $7.761M $13.07M $13.07M
YoY Change -40.6% 2.76% 2.76%
TOTAL ASSETS
Total Short-Term Assets $16.66M $13.11M $13.11M
Total Long-Term Assets $7.761M $13.07M $13.07M
Total Assets $24.42M $26.18M $26.18M
YoY Change -6.71% -25.92% -25.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.564M $1.239M $1.239M
YoY Change 26.23% -21.13% -21.13%
Accrued Expenses $4.010M $290.0K $3.067M
YoY Change 30.75% -55.93% -9.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.836M $255.0K $255.0K
YoY Change 1012.16% -96.2% -96.2%
Total Short-Term Liabilities $8.410M $4.851M $4.851M
YoY Change 73.37% -60.61% -60.61%
LONG-TERM LIABILITIES
Long-Term Debt $127.0K $2.803M $2.803M
YoY Change -95.47%
Other Long-Term Liabilities $839.0K $340.0K $1.336M
YoY Change -37.2% 17.65% 0.53%
Total Long-Term Liabilities $966.0K $4.139M $4.139M
YoY Change -76.66% 211.44% 211.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.410M $4.851M $4.851M
Total Long-Term Liabilities $966.0K $4.139M $4.139M
Total Liabilities $9.376M $8.990M $8.990M
YoY Change 4.29% -34.11% -34.11%
SHAREHOLDERS EQUITY
Retained Earnings $2.743M
YoY Change -36.74%
Common Stock $14.62M
YoY Change -17.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.04M $17.19M $17.19M
YoY Change
Total Liabilities & Shareholders Equity $24.42M $26.18M $26.18M
YoY Change -6.71% -25.92% -25.92%

Cashflow Statement

Concept 2019 2018 Q2 2018
OPERATING ACTIVITIES
Net Income -$1.754M -$1.454M -$1.593M
YoY Change 10.11% -39.62% -159.26%
Depreciation, Depletion And Amortization $1.728M $526.0K $1.858M
YoY Change -7.0% -2.59% -6.49%
Cash From Operating Activities -$1.427M $429.0K $396.0K
YoY Change -460.35% -170.33% -107.06%
INVESTING ACTIVITIES
Capital Expenditures $1.272M -$359.0K $1.132M
YoY Change 12.37% -32.26% -30.55%
Acquisitions
YoY Change
Other Investing Activities $7.836M $13.00K $425.0K
YoY Change 1743.76% -97.59% -97.89%
Cash From Investing Activities $6.392M -$346.0K -$1.436M
YoY Change -545.13% -107.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $383.0K $3.072M
YoY Change -87.53% 379.25%
Debt Paid & Issued, Net $296.0K $3.926M
YoY Change -92.46% -1.48%
Cash From Financing Activities -679.0K -168.0K -5.998M
YoY Change -88.68% 20.0% 6.61%
NET CHANGE
Cash From Operating Activities -1.427M 429.0K 396.0K
Cash From Investing Activities 6.392M -346.0K -1.436M
Cash From Financing Activities -679.0K -168.0K -5.998M
Net Change In Cash 4.286M -85.00K -7.038M
YoY Change -160.9% -88.67% -197.3%
FREE CASH FLOW
Cash From Operating Activities -$1.427M $429.0K $396.0K
Capital Expenditures $1.272M -$359.0K $1.132M
Free Cash Flow -$2.699M $788.0K -$736.0K
YoY Change 266.71% -1085.0% -89.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1531000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13971000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5896000
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1470000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-2314000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-1112000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2078000
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000096793
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2019 dei Entity Registrant Name
EntityRegistrantName
SUNLINK HEALTH SYSTEMS INC
CY2018 us-gaap Labor And Related Expense
LaborAndRelatedExpense
18610000
CY2018 us-gaap Supplies Expense
SuppliesExpense
1238000
CY2018 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3657000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
615000
CY2019 dei Trading Symbol
TradingSymbol
SSY
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3456000
CY2019Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
4715000
CY2018Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
4823000
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6986855
CY2018Q4 dei Entity Public Float
EntityPublicFloat
4884050
CY2019Q2 us-gaap Inventory Net
InventoryNet
2016000
CY2018Q2 us-gaap Inventory Net
InventoryNet
1854000
CY2019 dei Entity File Number
EntityFileNumber
1-12607
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
310621189
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
900 Circle 75 Parkway
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1120
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
Georgia
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
CY2019 dei City Area Code
CityAreaCode
770
CY2019 dei Local Phone Number
LocalPhoneNumber
933-7000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7742000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2185000
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2977000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
16658000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
13110000
CY2019Q2 us-gaap Land
Land
273000
CY2018Q2 us-gaap Land
Land
754000
CY2019Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5429000
CY2018Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5823000
CY2019Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
13818000
CY2018Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
13290000
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19867000
CY2018Q2 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
305000
CY2018Q2 ssy Assets Held For Sale Not Part Of Disposal Group Noncurrent
AssetsHeldForSaleNotPartOfDisposalGroupNoncurrent
4510000
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1207000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8410000
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
127000
CY2019Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
705000
CY2018Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1157000
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19520000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14277000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5243000
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1353000
CY2018Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2803000
CY2018Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
996000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7347000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4851000
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7347000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45209000
CY2019Q2 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
153000
CY2019Q2 ssy Assets Held For Sale Not Part Of Disposal Group Noncurrent
AssetsHeldForSaleNotPartOfDisposalGroupNoncurrent
249000
CY2019 us-gaap Profit Loss
ProfitLoss
-1754000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1728000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
8000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
455000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-571000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-82000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-345000
CY2019 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1996000
CY2018 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-226000
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
242000
CY2018 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1367000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-1754000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-76000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
150000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1830000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1443000
CY2019 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.28
CY2018 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2019 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.28
CY2018 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
CY2018 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.17
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.03
CY2018 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.17
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7149000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8283000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7149000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8283000
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21693000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
296000
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3926000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7742000
CY2018 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
944000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-238000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1427000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
134000
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
340000
CY2019Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
966000
CY2018Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4139000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
3493000
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
3673000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
10745000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
10947000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1058000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2743000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-253000
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-177000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15043000
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17186000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24419000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26176000
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000
CY2018Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000
CY2019Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2018Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6987000
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6987000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45618000
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
19191000
CY2019 us-gaap Supplies Expense
SuppliesExpense
1241000
CY2019 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3895000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
609000
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
129000
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1486000
CY2019 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
68000
CY2018 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
21000
CY2019 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
22000
CY2018 us-gaap Interest Expense
InterestExpense
359000
CY2019 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
455000
CY2018 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
194000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-1593000
CY2018 ssy Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax
OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax
150000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8000
CY2018 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3072000
CY2019 ssy Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax
OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax
-7000
CY2019 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
0
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1000
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
383000
CY2018 ssy Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax
OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax
103000
CY2019 ssy Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax
OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax
0
CY2018 us-gaap Profit Loss
ProfitLoss
-1593000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1858000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
194000
CY2019Q2 ssy Cash Deposits In Excess Of Federally Insured Limits
CashDepositsInExcessOfFederallyInsuredLimits
762000
CY2019 us-gaap Interest Expense
InterestExpense
241000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2019 us-gaap Interest Paid Net
InterestPaidNet
222000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1049000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1190000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-391000
CY2019 ssy Increase Decrease In Third Party Payor Settlements
IncreaseDecreaseInThirdPartyPayorSettlements
218000
CY2018 ssy Increase Decrease In Third Party Payor Settlements
IncreaseDecreaseInThirdPartyPayorSettlements
368000
CY2019 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-907000
CY2018 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-264000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
396000
CY2019 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
6899000
CY2018 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
937000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
425000
CY2019 ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
1272000
CY2018 ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
1132000
CY2019 ssy Payments To Acquire Property Plant And Equipment Discontinuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuingOperations
172000
CY2018 ssy Payments To Acquire Property Plant And Equipment Discontinuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuingOperations
729000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
383000
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3072000
CY2019 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
0
CY2018 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
1000000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-679000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5998000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4286000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7038000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3456000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10494000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
319000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
680142
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
651000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.80
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.52
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8000
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3D
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
74000
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
74000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2019 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">13. ECONOMIC DAMAGES</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Pharmacy Segment subsidiary asserted claims for economic damages in connection with the Deepwater Horizon Settlement Program related to the event which occurred in 2010. In January 2018, these claims were settled and payments of approximately $22 and $944 (net of costs and attorneys&#8217; fees) for years ended June 30, 2019 and 2018 were received. The net settlements are recognized as a gain in the results for those respective years.</p>
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Management Estimates<font style="font-weight:normal;font-style:normal;"> &#8212;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates made by management involve reserves for adjustments to net patient service revenues, evaluation of the recoverability of assets, including accounts receivable and intangible assets, and the assessment of litigation and contingencies, including income taxes and related tax asset valuation allowances, all as discussed in more detail in the remainder of these notes to the consolidated financial statements. Actual results could differ materially from these estimates.</font></p>
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk<font style="font-weight:normal;font-style:normal;"> &#8212;SunLink&#8217;s Healthcare Services segment subsidiaries grant unsecured credit to their patients, most of who reside in the service area of the subsidiaries&#8217; facilities and are insured under third-party agreements. Medicare and Medicaid patient accounts represent SunLink&#8217;s only significant concentrations of credit risk. For SunLink&#8217;s Healthcare Services segment, Medicare net revenues were approximately 49% and 50% of net revenues for the years ended June&#160;30, 2019 and 2018, respectively. For SunLink&#8217;s Healthcare Services segment, Medicaid was approximately 33% and 31% net revenues for the years ended June&#160;30, 2019 and 2018, respectively. For SunLink&#8217;s Healthcare Services segment, Medicare receivables were approximately 42% and 45% of receivables&#8212;net at June&#160;30, 2019 and 2018, respectively, while Medicaid receivables were approximately 26% and 36% of receivables&#8212;net at June&#160;30, 2019 and 2018, respectively.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SunLink&#8217;s Pharmacy segment subsidiary grants unsecured credit to individual customers and institutional customers.&#160;Individual customers primarily are insured under third-party agreements, including Medicare and Medicaid, while the institutional customers are granted credit according to their determined credit risk.&#160;Medicare receivables were approximately 17% and 19% of the Pharmacy segment&#8217;s receivables at June&#160;30, 2019 and 2018, respectively, while Medicaid receivables were approximately 17% and 18% of the Pharmacy segments receivable at June&#160;30, 2019 and 2018, respectively. Approximately 66% and 63% of the Pharmacy&#8217;s net receivables at June&#160;30, 2019 and 2018, respectively, were private insurance and institutional customers&#8217; receivables. Net revenues for the Pharmacy segment for the fiscal year ended June&#160;30, 2019 and 2018 were approximately 35% and 35% Medicare, respectively, and approximately 29% and 26% Medicaid, respectively.</p>
CY2019 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2019 us-gaap Charity Care Reimbursements Received
CharityCareReimbursementsReceived
48000
CY2018 us-gaap Charity Care Reimbursements Received
CharityCareReimbursementsReceived
8000
CY2019Q2 us-gaap Cash
Cash
1742000
CY2019 ssy Maturity Period Of Certificates Of Deposit
MaturityPeriodOfCertificatesOfDeposit
P3M
CY2019 ssy Overnight Repurchase Agreements Collateralized By Government Backed Securities
OvernightRepurchaseAgreementsCollateralizedByGovernmentBackedSecurities
1.02
CY2019 ssy Maximum Period Of Accounts Receivable Written Off
MaximumPeriodOfAccountsReceivableWrittenOff
P120D
CY2019 us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
Depreciation is recognized over the estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2019 us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
Estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2019 us-gaap Depreciation
Depreciation
1369000
CY2018 us-gaap Depreciation
Depreciation
1414000
CY2019 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
4993000
CY2018 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
7042000
CY2019 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1812000
CY2018 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1254000
CY2019 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
2136000
CY2018 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-113000
CY2019 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
82000
CY2018 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18529000
CY2018 us-gaap Operating Expenses
OperatingExpenses
46321000
CY2019Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5230000
CY2018Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5352000
CY2019Q2 ssy Long Term Debt Contractual Commitments For Interest In Year Five
LongTermDebtContractualCommitmentsForInterestInYearFive
0
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
515000
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
529000
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
821000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
552000
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1235000
CY2019 ssy Health Care Organization Significant Change In Estimates
HealthCareOrganizationSignificantChangeInEstimates
-15000
CY2018 ssy Health Care Organization Significant Change In Estimates
HealthCareOrganizationSignificantChangeInEstimates
135000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
117000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
117000
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
100000
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
26000
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
26000
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
21000
CY2019Q2 ssy Finite Lived Intangible Assets Amortization Expense Year Five And Thereafter Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndThereafterFive
0
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
173000
CY2019Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
159000
CY2018Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3158000
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3277000
CY2019Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
195000
CY2018Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
219000
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2836000
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
255000
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
127000
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2803000
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
3031000
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
34000
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
36000
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
39000
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
18000
CY2019Q2 ssy Long Term Debt Contractual Commitments For Interest In Next Twelve Months
LongTermDebtContractualCommitmentsForInterestInNextTwelveMonths
186000
CY2019Q2 ssy Long Term Debt Contractual Commitments For Interest In Year Two
LongTermDebtContractualCommitmentsForInterestInYearTwo
8000
CY2019Q2 ssy Long Term Debt Contractual Commitments For Interest In Year Three
LongTermDebtContractualCommitmentsForInterestInYearThree
5000
CY2019Q2 ssy Long Term Debt Contractual Commitments For Interest In Year Four
LongTermDebtContractualCommitmentsForInterestInYearFour
3000
CY2019Q2 ssy Long Term Debt Contractual Commitments
LongTermDebtContractualCommitments
202000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
29142
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
56000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
636000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
595000
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.00
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.46
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.53
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.52
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.53
CY2018 ssy Share Based Payment Award Options Forfeited In Period Range Of Exercise Price
ShareBasedPaymentAwardOptionsForfeitedInPeriodRangeOfExercisePrice
8.00
CY2018Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
300000
CY2019 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
359959
CY2018Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
450000
CY2019 ssy Stock Repurchased During Period Value Excluding Fees And Expenses
StockRepurchasedDuringPeriodValueExcludingFeesAndExpenses
372000
CY2019Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
390041
CY2019 ssy Share Repurchase Average Price Per Share Paid
ShareRepurchaseAveragePricePerSharePaid
1.03
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-327000
CY2018 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
150000
CY2018 ssy Tax Cuts And Jobs Act Change In Tax Rate Discrete Net Tax Benefit
TaxCutsAndJobsActChangeInTaxRateDiscreteNetTaxBenefit
0
CY2019Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
16700000
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-177000
CY2019 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-76000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-253000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-327000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-82000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-345000
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6766000
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6367000
CY2019Q2 ssy Deferred Tax Assets Depreciation Expense
DeferredTaxAssetsDepreciationExpense
46000
CY2018Q2 ssy Deferred Tax Assets Depreciation Expense
DeferredTaxAssetsDepreciationExpense
-97000
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
125000
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
111000
CY2019Q2 ssy Deferred Tax Assets Accrued Expenses
DeferredTaxAssetsAccruedExpenses
603000
CY2018Q2 ssy Deferred Tax Assets Accrued Expenses
DeferredTaxAssetsAccruedExpenses
617000
CY2019Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
877000
CY2018Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1185000
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
141000
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
132000
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
58000
CY2018Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8373000
CY2018Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8373000
CY2019Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2018Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-407000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2889000
CY2018 us-gaap Income Tax Reconciliation Tax Settlements State And Local
IncomeTaxReconciliationTaxSettlementsStateAndLocal
1000
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
32000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
2971000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-11000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-21000
CY2019Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2019 ssy Net Operating Loss Carry Forwards Expire Period
NetOperatingLossCarryForwardsExpirePeriod
2023 through fiscal 2038
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 ssy Tax Cuts And Jobs Act Of2017 Changes In Valuation Allowance Position
TaxCutsAndJobsActOf2017ChangesInValuationAllowancePosition
0
CY2019 ssy Tax Cuts And Jobs Act Of2017 Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ProvisionalIncomeTaxExpenseBenefit
0
CY2018Q2 ssy Tax Cuts And Jobs Act Of2017 Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
TaxCutsAndJobsActOf2017DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
305000
CY2018 ssy Additional Income Tax Expense Benefit
AdditionalIncomeTaxExpenseBenefit
40000
CY2018Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
296000
CY2019 ssy Tax Cuts And Jobs Act Of2017 Accounting Complete
TaxCutsAndJobsActOf2017AccountingComplete
true
CY2019Q2 ssy Plans Assets Invested In Cash And Short Term Investments
PlansAssetsInvestedInCashAndShortTermInvestments
0.44
CY2019Q2 ssy Plans Assets Invested In Equity Investments
PlansAssetsInvestedInEquityInvestments
0.38
CY2019Q2 ssy Plans Assets Invested In Fixed Income Investments
PlansAssetsInvestedInFixedIncomeInvestments
0.18
CY2019 ssy Expected Return On Investment
ExpectedReturnOnInvestment
0.04
CY2019Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
88000
CY2019Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
50000
CY2019Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
48000
CY2017Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
1506000
CY2019Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
59000
CY2019Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
57000
CY2019Q2 ssy Plan Expected To Pay In Pension Benefits Through Three Years
PlanExpectedToPayInPensionBenefitsThroughThreeYears
430000
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
107000
CY2018 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
100000
CY2019Q2 us-gaap Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
132000
CY2019 ssy Age Of Participants To Take Monthly Pension Benefits One
AgeOfParticipantsToTakeMonthlyPensionBenefitsOne
P65Y
CY2019 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0410
CY2018 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0380
CY2019 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0400
CY2018 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0400
CY2019 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0.0000
CY2018 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0.0000
CY2018Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
1420000
CY2019 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
56000
CY2018 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
55000
CY2019 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
90000
CY2018 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-47000
CY2019 us-gaap Defined Benefit Plan Benefit Obligation Benefits Paid
DefinedBenefitPlanBenefitObligationBenefitsPaid
176000
CY2018 us-gaap Defined Benefit Plan Benefit Obligation Benefits Paid
DefinedBenefitPlanBenefitObligationBenefitsPaid
94000
CY2018Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
895000
CY2017Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
891000
CY2019 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
1000
CY2018 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
-2000
CY2019 us-gaap Defined Benefit Plan Plan Assets Benefits Paid
DefinedBenefitPlanPlanAssetsBenefitsPaid
176000
CY2018 us-gaap Defined Benefit Plan Plan Assets Benefits Paid
DefinedBenefitPlanPlanAssetsBenefitsPaid
94000
CY2019Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
827000
CY2019Q2 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-563000
CY2018Q2 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-525000
CY2019 ssy Unrecognized Actuarial Loss
UnrecognizedActuarialLoss
384000
CY2018 ssy Unrecognized Actuarial Loss
UnrecognizedActuarialLoss
376000
CY2019Q2 ssy Prepaid Accrued Benefit Cost
PrepaidAccruedBenefitCost
-179000
CY2018Q2 ssy Prepaid Accrued Benefit Cost
PrepaidAccruedBenefitCost
-149000
CY2019Q2 ssy Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost
DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost
-179000
CY2018Q2 ssy Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost
DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost
-149000
CY2019Q2 ssy Defined Benefit Plans Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax
DefinedBenefitPlansAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax
384000
CY2018Q2 ssy Defined Benefit Plans Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax
DefinedBenefitPlansAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax
376000
CY2019Q2 us-gaap Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
-563000
CY2018Q2 us-gaap Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
-525000
CY2019 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
0
CY2018 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
0
CY2019 ssy Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
85000
CY2018 ssy Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
157000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
592000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
330000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
129000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3000
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1054000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1272000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1132000
CY2019 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1996000
CY2018 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-226000
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
61000

Files In Submission

Name View Source Status
0001564590-19-035757-index-headers.html Edgar Link pending
0001564590-19-035757-index.html Edgar Link pending
0001564590-19-035757.txt Edgar Link pending
0001564590-19-035757-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssy-10k_20190630.htm Edgar Link pending
ssy-20190630.xml Edgar Link completed
ssy-20190630.xsd Edgar Link pending
ssy-20190630_cal.xml Edgar Link unprocessable
ssy-20190630_def.xml Edgar Link unprocessable
ssy-20190630_lab.xml Edgar Link unprocessable
ssy-20190630_pre.xml Edgar Link unprocessable
ssy-ex211_11.htm Edgar Link pending
ssy-ex231_10.htm Edgar Link pending
ssy-ex311_9.htm Edgar Link pending
ssy-ex312_8.htm Edgar Link pending
ssy-ex321_7.htm Edgar Link pending
ssy-ex322_6.htm Edgar Link pending
ssy-ex43_278.htm Edgar Link pending